Roche made a splash last year with its repeated overtures to acquire genome sequencing firm Illumina, but for the most part, 2012 was a quiet year during which players in the life sciences industry took modest steps to increase their capabilities to advance personalized treatment
NEW YORK (GenomeWeb News) – Biopharmaceutical firm Amgen is acquiring genomic research products firm Decode Genetics for $415 million, the companies announced today. The all-cash deal has been approved by Amgen's board and is expected to be completed before the end of the year.
A consortium of 18 European and Australian institutions and industry partners will spend five years sequencing the exomes of 1,100 patients with neurodegenerative and neuromuscular diseases to create diagnostic panels and uncover novel therapeutic targets.
NEW YORK (GenomeWeb News) – A pair of studies that appeared in The New England Journal of Medicine this week identified a rare variant of the TREM2 gene as a potent risk factor for late-onset Alzheimer's disease.
While the last decade saw the rise – and sometimes fall – of a number of direct-to-consumer genomics firms, including 23andMe, Navigenics, and Decode Genetics, the market for DTC proteomics has remained largely unexplored.
NEW YORK (GenomeWeb News) – The most recent mingling between modern humans outside of Africa and Neandertals appears to have occurred during the late Stone Age, according to a new genetic analysis by American and German researchers.